Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Phibro Animal Health (PAHC) Leases (2019 - 2026)

Phibro Animal Health has reported Leases over the past 7 years, most recently at $39.4 million for Q4 2025.

  • For Q4 2025, Leases rose 5.51% year-over-year to $39.4 million; the TTM value through Dec 2025 reached $39.4 million, up 5.51%, while the annual FY2025 figure was $41.3 million, 9.93% up from the prior year.
  • Leases for Q4 2025 was $39.4 million at Phibro Animal Health, down from $40.1 million in the prior quarter.
  • Over five years, Leases peaked at $42.2 million in Q1 2025 and troughed at $31.7 million in Q3 2021.
  • A 5-year average of $36.8 million and a median of $37.2 million in 2024 define the central range for Leases.
  • Biggest five-year swings in Leases: soared 44.19% in 2021 and later decreased 5.79% in 2023.
  • Year by year, Leases stood at $32.3 million in 2021, then grew by 10.87% to $35.8 million in 2022, then increased by 6.71% to $38.2 million in 2023, then decreased by 2.1% to $37.4 million in 2024, then grew by 5.51% to $39.4 million in 2025.
  • Business Quant data shows Leases for PAHC at $39.4 million in Q4 2025, $40.1 million in Q3 2025, and $41.3 million in Q2 2025.